147 related articles for article (PubMed ID: 28002594)
1. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis.
Wang YL; Gong WG; Yuan QL
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002594
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
[TBL] [Abstract][Full Text] [Related]
4. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.
Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
Biomed Pharmacother; 2017 Nov; 95():1718-1724. PubMed ID: 28962076
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.
Shang D; Xie C; Hu J; Tan J; Yuan Y; Liu Z; Yang Z
J Cell Mol Med; 2020 Jan; 24(1):588-604. PubMed ID: 31724333
[TBL] [Abstract][Full Text] [Related]
6. miR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.
Li WQ; Yu HY; Zhong NZ; Hou LJ; Li YM; He J; Liu HM; Xia CY; Lu YC
Int J Oncol; 2015 Apr; 46(4):1601-8. PubMed ID: 25626081
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
Wang Z; Zhang H; Zhang P; Dong W; He L
Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
[TBL] [Abstract][Full Text] [Related]
8. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
9.
Vosgha H; Ariana A; Smith RA; Lam AK
Endocr Relat Cancer; 2018 Mar; 25(3):323-337. PubMed ID: 29317480
[TBL] [Abstract][Full Text] [Related]
10. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
Zhu J; Liu F; Wu Q; Liu X
Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
[TBL] [Abstract][Full Text] [Related]
11. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.
Colangelo T; Polcaro G; Ziccardi P; Pucci B; Muccillo L; Galgani M; Fucci A; Milone MR; Budillon A; Santopaolo M; Votino C; Pancione M; Piepoli A; Mazzoccoli G; Binaschi M; Bigioni M; Maggi CA; Fassan M; Laudanna C; Matarese G; Sabatino L; Colantuoni V
Cell Death Dis; 2016 Feb; 7(2):e2120. PubMed ID: 26913609
[TBL] [Abstract][Full Text] [Related]
12. AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo.
Ge YF; Sun J; Jin CJ; Cao BQ; Jiang ZF; Shao JF
Asian Pac J Cancer Prev; 2013; 14(2):963-8. PubMed ID: 23621269
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts.
Wang J; Guan X; Zhang Y; Ge S; Zhang L; Li H; Wang X; Liu R; Ning T; Deng T; Zhang H; Jiang X; Ba Y; Huang D
Cell Physiol Biochem; 2018; 49(3):869-883. PubMed ID: 30184548
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.
Zhao Q; Li Y; Tan BB; Fan LQ; Yang PG; Tian Y
PLoS One; 2015; 10(8):e0132746. PubMed ID: 26292288
[TBL] [Abstract][Full Text] [Related]
16. MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1.
Gu L; Sun W
Biochem Biophys Res Commun; 2015 Sep; 464(4):1128-1133. PubMed ID: 26206083
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer.
Guan H; Wei G; Wu J; Fang D; Liao Z; Xiao H; Li M; Li Y
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1334-44. PubMed ID: 23720784
[TBL] [Abstract][Full Text] [Related]
18. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.
Ding C; Yu H; Shi C; Shi T; Qin H; Cui Y
Biomed Pharmacother; 2019 Feb; 110():528-536. PubMed ID: 30530288
[TBL] [Abstract][Full Text] [Related]
19. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
20. Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.
Toden S; Okugawa Y; Buhrmann C; Nattamai D; Anguiano E; Baldwin N; Shakibaei M; Boland CR; Goel A
Cancer Prev Res (Phila); 2015 May; 8(5):431-43. PubMed ID: 25712055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
